🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to determine the pharmacokinetic profile and the tolerabili...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08
Trial ID
NCT01529294
Treatments Being Tested
The purpose of the study is to determine whether motivation/reward deficits...
Status
Completed
Location
Kings College London
Start Date
2017-12-21
Trial ID
NCT03319953
Treatments Being Tested
This study is designed as a 3-part trial to evaluate the safety of a novel ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-04
Trial ID
NCT01348100
Treatments Being Tested
This is an open-label, sequential cohorts, flexible dose study to evaluate ...
Status
Withdrawn
Location
Vanda Investigational Site
Start Date
2022-06
Trial ID
NCT05344365
Treatments Being Tested
The study looks at whether treatment with iloperidone (Fanapt) is associate...
Status
Terminated
Location
Northwestern University
Start Date
2012-04
Trial ID
NCT01929889
Treatments Being Tested
1. To assess the acute and long-term bimodal efficacy of iloperidone (IL), ...
Status
Completed
Location
UT Health Science Center San Antonio
Start Date
2012-04
Trial ID
NCT02413918
Treatments Being Tested
The purpose of this study is to extend the recent Food and Drug Administrat...
Status
Completed
Location
Janssen Investigative Site
Start Date
2019-05-06
Trial ID
NCT04002700
Treatments Being Tested
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evalua...
Status
Recruiting
Location
Vanda Investigative Site
Start Date
2025-09-15
Trial ID
NCT07090161
Treatments Being Tested
Evaluate the clinical outcome of two switching strategies to iloperidone tr...
Status
Completed
Location
Birmingham Psychiatry Pharmaceutical Studies, Inc.
Start Date
2010-08
Trial ID
NCT01207414
Treatments Being Tested
Tolerability, undertstanding of the action of the drug in the body, and und...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-10
Trial ID
NCT01495169
Treatments Being Tested